Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
about
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Breast cancer treatment and chemoprevention.American Joint Committee on Cancer prognostic factors consensus conference.Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.Current status of diagnosis and treatment of primary breast cancer in beijing, 2008.Reading between the lines: direct-to-consumer advertising of genetic testing.Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.Options in breast cancer local therapy: who gets what?Extended Endocrine Therapy: Is 5 Years Enough?The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer.Lymphatic mapping and sentinel node biopsy in breast cancer.Time-varying effects of prognostic factors associated with long-term survival in breast cancer.The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
P2860
Q30245184-725BF3FB-6B13-4AD7-A4A1-AEF4F205A4C5Q33720741-EB532A76-966E-416A-BB32-02E0ACA7D08BQ33789795-D21DB2FA-BD64-4424-8FF9-726CE8767C16Q33879820-2CD45E23-5A5E-4857-8860-CA282969B99FQ35000713-1E9D0C8B-92D2-437E-89B6-31D08D0DB9D1Q35076216-FDEA0C4C-F4C4-4348-B42E-DE320A9B7E4CQ35558096-BA6CECAB-261B-4C00-BBDB-39370867ED6CQ35593300-C7F87C7B-DBC3-48AD-A1A4-B446C1971D75Q36070063-E5CB9118-BBB5-4298-B3F9-C441B080FA81Q36614283-F91F97C6-5864-4982-9C84-C81F5FE6569BQ36616513-62BDC8BF-6FFE-4DFD-8591-5CF1A0715075Q36654622-A18D79DE-54A0-4098-B215-F459AD70EBC8Q36733976-ECCE3967-00B9-468D-9987-C4E5384CB2EBQ37657782-4DCD4D4B-BF25-4E55-9D9B-A64DC5CFB022Q37989842-D290B319-ECC9-4623-A703-F8DF51143EA7Q38934318-E051E745-DE17-41F5-B0B7-AB8BF19A61A1Q38963009-ADECD4CD-5F9E-43A5-8EDF-CE940A3359B2Q50522177-D2728679-9746-4633-9803-13FF433DBDBAQ52689274-B37BFB04-2868-4ACE-A2C2-2FA22A3AF546Q53571481-4308E33E-D67B-463A-BE38-AE35288A5E12
P2860
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@en
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@nl
type
label
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@en
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@nl
prefLabel
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@en
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@nl
P2093
P1476
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
@en
P2093
P304
P356
10.1200/JCO.1991.9.9.1650
P407
P577
1991-09-01T00:00:00Z